2026 Diagnostics Trends
Download the full 2026 Diagnostics Trends Report here.
This free trends report outlines industry perspectives and expert advice from our team of life sciences consultants. You can view an excerpt of the report below, and if you’d like to discuss any of the trends or other challenges in the diagnostics space, connect with our team today.
Key Diagnostics Trends
The diagnostics industry is being shaped by the push towards telemedicine and remote solutions, proactive over reactive healthcare, the fight against antimicrobial resistance, and affordability in diagnostic testing. It’s imperative that businesses identify ways to incorporate advanced technologies and develop innovative diagnostic testing that allows for faster, more accurate results while addressing data security and cost concerns associated with the new world of diagnostics.
Given our deep industry knowledge, Clarkston is well-suited to help businesses in successfully navigating these changes – whether it’s exploring new data storage and analysis options, conducting supply chain landscape assessments, or incorporating AI in your diagnostic research. Reach out to our team to learn more about how these advancements are influencing healthcare in the future and how we can work with you to stay ahead of the curve in this ever-evolving market.
Clarkston’s life sciences consultants have highlighted the top diagnostics industry trends that businesses should consider and keep top-of-mind throughout the year:
- Continued Growth of Remote Diagnostics
- Shifting from Reactive to Proactive Care with Personalized Diagnostics
- Fighting Antimicrobial Resistance with Diagnostics
- Affordability is a Key Barrier in Molecular Diagnostics Adoption
Trend 1:
Continued Growth of Remote Diagnostics
The remote diagnostics sector continues to advance in line with the growth of digitization as a whole. Patients and healthcare providers alike appreciate the accessibility and flexibility that telemedicine and virtual care offer, but sustained progress will depend on more than convenience alone. Continued advancements in remote diagnostics are increasingly intertwined with digital infrastructure and data-enabled care models.
We are starting to witness a strong correlation between the upward trend of personalized medicine and remote diagnostics with wearable devices, such as continuous glucose monitors, blood pressure monitors, and even smart clothing integrated with sensors. These tools can provide real-time notifications regarding the status of a patient’s health, offering diagnostic solutions more quickly and cutting out the inconveniences of on-site visits.
Many individuals are familiar anecdotally, if not from personal experience, with telemedicine. For years, and especially after the Covid-19 outbreak, virtual doctor appointments have been a convenient option to seek clinical advice and diagnoses based on descriptions of symptoms. The world of remote diagnostics continues to evolve as now clinicians aren’t only able to rely on phone and video calls to interact with their patients but can also analyze digital images of molecular samples remotely.
One of the most critical challenges and concerns impacting patients in remote diagnostics is data privacy, particularly with the global remote diagnostics market size expected to reach $653.29 billion by 2033. Advanced technology in data storage and analysis, such as cloud-based data infrastructure, will play an important role in resolving the data security and privacy concerns associated with remote diagnostics.
Trend 2:
Shifting from Reactive to Proactive Care with Personalized Diagnostics
The U.S. healthcare system has long functioned in a reactive manner, identifying illnesses in patients and developing treatment plans based on their symptoms or more detailed diagnoses – in fact, reactive treatment currently consumes over 75% of healthcare spending in the U.S. As cost pressures intensify, one of the most valuable cost-saving strategies in healthcare is to invest in prevention rather than treatments.
The rise in proactive healthcare is reshaping expectations for the diagnostics industry. To support earlier intervention, diagnostic tools must deliver insights and results sooner and faster than ever, often before symptoms are even evident. Personalized or precision medicine plays a pivotal role in this evolution; even as the focus moves upstream toward prevention, the need for diagnostic testing remains strong, particularly as testing becomes more individualized and embedded in long-term disease management and therapeutic research.
With personalized medicine, tools like wearable monitors enable live, real-time tracking of patient data, supporting earlier recognition of potential health concerns. Diagnostic tools such as Sepsis Watch demonstrate how advanced analytics can be applied to diagnostic data to identify deterioration sooner and guide timely intervention. Similarly, methodologies such as AI-enabled continuous glucose monitoring – which allows proactive forecasting of glucose levels – are proving helpful in enhancing predictive diagnostics and for risk modeling to identify high-risk individuals based on biological markers before symptoms arise.
Incorporating AI-powered analysis and data modeling tools can aid in analyzing trends, developing care plans, detecting abnormal patterns, and providing alerts to enable early intervention. These capabilities are helping shifting the industry from one centered on treating disease to one focused on anticipating and preventing it.
Continue reading by downloading the full report below.
Download the Full 2026 Diagnostics Trends Report Here
Read last year’s Diagnostics Trends Report here.



